Fernando Valiente‐Echeverría

2.4k total citations
54 papers, 1.3k citations indexed

About

Fernando Valiente‐Echeverría is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Fernando Valiente‐Echeverría has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Infectious Diseases and 11 papers in Virology. Recurrent topics in Fernando Valiente‐Echeverría's work include RNA Research and Splicing (19 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and RNA modifications and cancer (12 papers). Fernando Valiente‐Echeverría is often cited by papers focused on RNA Research and Splicing (19 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and RNA modifications and cancer (12 papers). Fernando Valiente‐Echeverría collaborates with scholars based in Chile, Canada and France. Fernando Valiente‐Echeverría's co-authors include Ricardo Soto‐Rifo, Andrew J. Mouland, Marcela A. Hermoso, Marcelo López‐Lastra, Daniela Toro‐Ascuy, Valerie Le Sage, Jorge Vera‐Otarola, Aracelly Gaete-Argel, Katia Abarca and Javier López and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Fernando Valiente‐Echeverría

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Valiente‐Echeverría Chile 24 710 447 271 187 176 54 1.3k
Han‐Qing Ye China 23 496 0.7× 592 1.3× 107 0.4× 212 1.1× 190 1.1× 62 1.4k
Steven M. Heaton Australia 11 378 0.5× 401 0.9× 61 0.2× 190 1.0× 49 0.3× 13 915
Aurélie Mousnier United Kingdom 22 717 1.0× 458 1.0× 338 1.2× 273 1.5× 30 0.2× 28 1.4k
Haran Sivakumaran Australia 15 392 0.6× 465 1.0× 236 0.9× 85 0.5× 28 0.2× 28 974
Nicholas J. Barrows United States 10 439 0.6× 597 1.3× 126 0.5× 209 1.1× 74 0.4× 11 1.3k
Michela Mazzon United Kingdom 15 348 0.5× 574 1.3× 383 1.4× 467 2.5× 65 0.4× 20 1.4k
Arthur S. Kim United States 23 580 0.8× 986 2.2× 234 0.9× 248 1.3× 104 0.6× 29 1.9k
Mingxia Sun China 20 401 0.6× 321 0.7× 56 0.2× 171 0.9× 146 0.8× 70 1.2k
Laurent Chatel‐Chaix Canada 23 828 1.2× 747 1.7× 427 1.6× 300 1.6× 146 0.8× 39 2.1k
David Alderton United Kingdom 8 512 0.7× 221 0.5× 127 0.5× 107 0.6× 34 0.2× 8 918

Countries citing papers authored by Fernando Valiente‐Echeverría

Since Specialization
Citations

This map shows the geographic impact of Fernando Valiente‐Echeverría's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Valiente‐Echeverría with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Valiente‐Echeverría more than expected).

Fields of papers citing papers by Fernando Valiente‐Echeverría

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Valiente‐Echeverría. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Valiente‐Echeverría. The network helps show where Fernando Valiente‐Echeverría may publish in the future.

Co-authorship network of co-authors of Fernando Valiente‐Echeverría

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Valiente‐Echeverría. A scholar is included among the top collaborators of Fernando Valiente‐Echeverría based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Valiente‐Echeverría. Fernando Valiente‐Echeverría is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hidalgo, Alejandro A., Rafael I. González, Juan Castro‐Severyn, et al.. (2025). Epidemiological surveillance and incidence of respiratory viruses in Chile: Before and after COVID 19. Infectio. 68–76.
2.
Gallardo, María José, et al.. (2024). 4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients. Frontiers in Immunology. 15. 1427501–1427501.
3.
Abreu, Cecilia, Aracelly Gaete-Argel, Fernando Valiente‐Echeverría, et al.. (2023). Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner. Frontiers in Immunology. 14. 1226880–1226880. 1 indexed citations
4.
Samudio, Angélica, et al.. (2023). Neutralizing antibodies from naturally infected individuals against SARS-CoV-2 Gamma and Delta variants in the Paraguayan population. The Journal of Infection in Developing Countries. 17(10). 1407–1412. 1 indexed citations
5.
Vargas, Leonardo, Fabián Tempio, Valeska Simon, et al.. (2022). Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies. BMC Medicine. 20(1). 216–216. 10 indexed citations
6.
Cáceres, C. Joaquín, et al.. (2021). Surveillance of seasonal respiratory viruses among Chilean patients during the COVID ‐19 pandemic. Health Science Reports. 4(4). e433–e433. 2 indexed citations
7.
Riquelme-Barrios, Sebastián, Aracelly Gaete-Argel, Adam Aguirre, et al.. (2021). Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile. Science Advances. 7(7). 20 indexed citations
8.
López‐Vergès, Sandra, Fernando Valiente‐Echeverría, Álex Godoy‐Faúndez, et al.. (2021). Call to Action: Supporting Latin American Early Career Researchers on the Quest for Sustainable Development in the Region. SHILAP Revista de lepidopterología. 6. 657120–657120. 8 indexed citations
9.
García-de-Gracia, Francisco, Aracelly Gaete-Argel, Sebastián Riquelme-Barrios, et al.. (2020). CBP80/20-dependent translation initiation factor (CTIF) inhibits HIV-1 Gag synthesis by targeting the function of the viral protein Rev. RNA Biology. 18(5). 745–758. 7 indexed citations
10.
Valiente‐Echeverría, Fernando, et al.. (2020). Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction. Journal of Virological Methods. 287. 113969–113969. 21 indexed citations
11.
Gaete-Argel, Aracelly, Chantal L. Márquez, Gonzalo P. Barriga, Ricardo Soto‐Rifo, & Fernando Valiente‐Echeverría. (2019). Strategies for Success. Viral Infections and Membraneless Organelles. Frontiers in Cellular and Infection Microbiology. 9. 336–336. 38 indexed citations
12.
Toro‐Ascuy, Daniela, Francisco García-de-Gracia, Aracelly Gaete-Argel, et al.. (2018). A Rev–CBP80–eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA. Nucleic Acids Research. 46(21). 11539–11552. 23 indexed citations
13.
Riquelme-Barrios, Sebastián, et al.. (2018). Emerging Roles of N6-Methyladenosine on HIV-1 RNA Metabolism and Viral Replication. Frontiers in Microbiology. 9. 576–576. 25 indexed citations
14.
Sage, Valerie Le, Alessandro Cinti, Fernando Valiente‐Echeverría, & Andrew J. Mouland. (2015). Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation. Virology Journal. 12(1). 138–138. 36 indexed citations
15.
Monette, Anne, et al.. (2013). Dual Mechanisms of Translation Initiation of the Full-Length HIV-1 mRNA Contribute to Gag Synthesis. PLoS ONE. 8(7). e68108–e68108. 41 indexed citations
16.
López, Javier, et al.. (2012). Identificación molecular de Ehrlichia canis en un canino de la ciudad de Arica, Chile. Revista chilena de infectología. 29(5). 527–530. 22 indexed citations
17.
López, Javier, et al.. (2012). Identificación morfológica y molecular de filarías caninas en una comuna semi-rural de la Región Metropolitana, Chile. Revista chilena de infectología. 29(3). 248–289. 33 indexed citations
18.
Valiente‐Echeverría, Fernando, et al.. (2011). Bocavirus humano en Chile: características clínicas y epidemiológicas en niños con infecciones respiratorias. Revista chilena de infectología. 28(6). 504–511. 7 indexed citations
19.
Deforges, Jules, Clara Abraham, Fernando Valiente‐Echeverría, et al.. (2011). Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factors. Nucleic Acids Research. 39(14). 6186–6200. 57 indexed citations
20.
Rivas‐Aravena, Andrea, Fernando Valiente‐Echeverría, Virginie Dormoy-Raclet, et al.. (2009). The Elav-like protein HuR exerts translational control of viral internal ribosome entry sites. Virology. 392(2). 178–185. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han‐Qing Ye Breakdown of academic impact, for papers by Steven M. Heaton Breakdown of academic impact, for papers by Aurélie Mousnier Breakdown of academic impact, for papers by Haran Sivakumaran Breakdown of academic impact, for papers by Nicholas J. Barrows Breakdown of academic impact, for papers by Michela Mazzon Breakdown of academic impact, for papers by Arthur S. Kim Breakdown of academic impact, for papers by Mingxia Sun Breakdown of academic impact, for papers by Laurent Chatel‐Chaix Breakdown of academic impact, for papers by David Alderton
Rankless by CCL
2026